Browsing: Novo Nordisk
Wegovy, the blockbuster weight-loss medication from Novo Nordisk A/S, eased heart-failure symptoms for patients with diabetes in the latest large trial…
The weight loss drug Wegovy secured a supplemental cardiovascular indication from the Food and Drug Administration last month. This allows…
Ozempic could be profitably produced for less than $5 a month even as maker Novo Nordisk A/S charges almost $1,000…
Workers today have much to be stressed out about; Geopolitical tensions are dominating their social media feeds, the cost of…
Topline Ozempic maker Novo Nordisk on Thursday teased a potential successor to its blockbuster weight loss drug Wegovy, the latest…
Amid a frenzy for AI-related stocks, shares of a little-known biotech company in South Korea got an Nvidia-esque boost. Alteogen,…
The popularity of Novo Nordisk’s weight-loss drugs has been unprecedented and has shown no signs of fading. It’s clearly more…
Novo Nordisk has shown few signs of slowing down since taking the pharmaceutical world by storm last year. Now, the…
North Carolina is cutting off coverage of anti-obesity medications for state employees, citing soaring costs and a lack of agreement…
Shares of Korea-listed Caregen surged on hope its diabetes-weight loss supplement could give the little-known biotech company an Ozempic-like boost.…